CollPlant Biotechnologies (CLGN) Common Equity (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Common Equity of $6.08 million for the quarter ended Dec 31, 2025, down 54.8% from $13.47 million a year earlier and down 34.6% from the prior quarter.
CollPlant Biotechnologies (CLGN) Common Equity (2017 - 2025) Analysis & Trends
Since the quarter ended Dec 31, 2017, CollPlant Biotechnologies has reported Common Equity for 31 quarters.
- Annual Common Equity has declined for four consecutive years, though with a five-year compound annual growth rate of 6.3% (years ended Dec 2020 to Dec 2025).
- In prior years, CollPlant Biotechnologies' Common Equity was $13.47 million in the year ended Dec 31, 2024 (-52.5%), $28.34 million in the year ended Dec 31, 2023 (-12.2%), $32.28 million in the year ended Dec 31, 2022 (-28.5%) and $45.12 million in the year ended Dec 31, 2021 (+907.8%).
- The figure for the quarter ended Dec 31, 2025 stands as the lowest quarterly Common Equity since the quarter ended Dec 31, 2020.
- On a year-over-year basis, Common Equity has declined in each of the last three quarters, with an average decline of 42.9% over the last seven quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was the quarter ended Dec 31, 2021, with growth of 907.8%; the weakest was the quarter ended Dec 31, 2025, with a decline of 54.8%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | CollPlant Biotechnologies | 4.95 Mn | 4.95 Mn | -243,000.00 | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.08 Mn |
| Sep 30, 2025 | 9.31 Mn |
| Jun 30, 2025 | 12.51 Mn |
| Dec 31, 2024 | 13.47 Mn |
| Sep 30, 2024 | 16.92 Mn |
| Jun 30, 2024 | 20.73 Mn |
| Mar 31, 2024 | 24.45 Mn |
| Dec 31, 2023 | 28.34 Mn |
| Sep 30, 2023 | 32.40 Mn |
| Jun 30, 2023 | 36.04 Mn |
| Mar 31, 2023 | 29.89 Mn |
| Dec 31, 2022 | 32.28 Mn |
| Sep 30, 2022 | 35.81 Mn |
| Jun 30, 2022 | 39.51 Mn |
| Mar 31, 2022 | 43.20 Mn |
| Dec 31, 2021 | 45.12 Mn |
| Sep 30, 2021 | 48.48 Mn |
| Jun 30, 2021 | 49.44 Mn |
| Mar 31, 2021 | 50.65 Mn |
| Dec 31, 2020 | 4.48 Mn |
CollPlant Biotechnologies Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CLGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();